FERMENTA BIOTECH
Back to Balance Sheet
|
FERMENTA BIOTECH Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹29 Cr | ₹77 Cr | ₹97 Cr | ₹154 Cr | ₹131 Cr |
What is the latest Total Non-Current Liabilities ratio of FERMENTA BIOTECH ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹29 Cr |
Mar2024 | ₹77 Cr |
Mar2023 | ₹97 Cr |
Mar2022 | ₹154 Cr |
Mar2021 | ₹131 Cr |
How is Total Non-Current Liabilities of FERMENTA BIOTECH Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹29 Cr | -62.03 | |
Mar2024 | ₹77 Cr | -20.94 | |
Mar2023 | ₹97 Cr | -36.76 | |
Mar2022 | ₹154 Cr | 17.22 | |
Mar2021 | ₹131 Cr | - |
Compare Total Non-Current Liabilities of peers of FERMENTA BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
FERMENTA BIOTECH | ₹1,069.3 Cr | 3.4% | 3.1% | 23% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹387,792.0 Cr | 2.3% | -0.4% | -12.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,986.0 Cr | 0% | 1.1% | 10.7% | Stock Analytics | |
CIPLA | ₹127,124.0 Cr | 2.1% | 3.5% | -4.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,700.0 Cr | -1.2% | -1.7% | 4.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,868.0 Cr | 5.3% | 7.9% | -2% | Stock Analytics |
FERMENTA BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
FERMENTA BIOTECH | 3.4% |
3.1% |
23% |
SENSEX | 1.5% |
1.6% |
0.4% |
You may also like the below Video Courses